Synthetic Biologics, Inc. (NYSE:SYN) could be one of the best stocks that investors may want to consider for their portfolio today as the company shares are trading 4% or 0.02 points up from last closing price of $0.5, reaching $0.52 at last check. Any clue why there is so much of action in the SYN stock? The share price has risen in 3 of the last 5 days and is down -38.89% over the past week. It will be exciting to see whether the stock manages to continue increasing or take a minor break for the next few days. The move came on solid volume too with far more shares changing hands than in a normal session. Trading activity as of this writing strengthened by 126,307 shares, and in total 175607 shares valued at $91316 were seen changing hands compared with 49300 shares valued at $24650 recorded at the previous session. You should take into consideration that a greater volume on higher prices causes bullish signal for the market. It shows the sentiment is in an uptrend and more and more traders want to enter in the SYN stock.
Synthetic Biologics, Inc. (SYN) shares have notched a 3-month decline of about -38.89%, but has still tumbled -11.61% year to date. By comparison, the stock sank -93.96% over the past 12 months, while it slipped -15.17% over the 1 month. The company’s market cap is around $8.17M, with its short interest ratio standing at 0.77%.
In the current trading session for SYN, the stock witnessed two major price actions, it rose to a high of $0.52 and was down as much as $0.4915 at one point. The high recorded is very low when compared to their 52-week high which is $0.49. The 52-week high is now at -94.32 distance from current price. Their recent low of $9.06 represents a 6.21% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for SYN is $2.25, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
SYN‘s last price was down -46.25% as compared to the average trading price of 50 days recorded at $0.97 while enlarging the period to 200 trading days, the average closing price was $0.59. At present, there are 16.5 million in the total number of common shares owned by the public and among those 16.47 million shares have been available to trade. The percentage of shares being held by the company management was 0.1% while institutions stake was 14.5%. The company has generated negative returns on equity over the last 12 months (0%). It managed to keep its gross profit margin at 0% over the past 12 months.
When assessing the full upside of the SYN stock, there is another set of technicals that should be looked into and considered. Its -3.09% decline from moving average of $0.54 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of 2.25 to the stock. With the beta been greater than one, this implies that the company shares are theoretically more volatile than the market, something that the traders definitely are keeping an eye on.
In the last five years, the EPS of the company has been roughly 15.5%. Though the percentage looks encouraging, extra headwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will decrease annually by 0%. The revenue of the company has retreated at an average annualized rate of about 0 over the last five years. The company recently recorded a drop of 0%, but this figure is rather unattractive.